Snowball logo
logo
6033

Guangxi Liuzhou Pharm Co Ltd

603368 • SHG
¥15.03-¥0.09  (0.6%)
Estimate
P/E
9.2
EPS
1.64
Beta
0.366
Growth
Revenue, YoY
3.31%
Net income, YoY
-4.85%
FCF, YoY
8.87%
Forecast
P/E (FWD)
8.4
EPS (FWD)
1.78
About the company
Ticker
603368
ISIN
CNE100001VR3
Country
China
Sector (GICS)
Healthcare
Guangxi LiuYao Group Co., Ltd engages in the manufacturing, wholesale, and retail of pharmaceutical products in China. It offers various types of medicines, medical devices, consumables, diagnostic reagents, other innovative drugs, and self-produced products through online pharmacies and terminal physical pharmacies. The company also offers health consultations and engages in food manufacturing. Guangxi LiuYao Group Co., Ltd was founded in 1981 and is based in Liuzhou, China.

Frequently asked questions

What sector does Guangxi Liuzhou Pharm Co Ltd (603368) operate in?

Guangxi Liuzhou Pharm Co Ltd belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is Guangxi Liuzhou Pharm Co Ltd (603368) current stock price?

As of the latest data, Guangxi Liuzhou Pharm Co Ltd stock price is CN¥15.03, with a previous close of CN¥15.12. Guangxi Liuzhou Pharm Co Ltd lost -CN¥0.09 in the last trading session, representing a -0.6% loss.

What is Guangxi Liuzhou Pharm Co Ltd (603368) current market capitalization?

Guangxi Liuzhou Pharm Co Ltd market cap is approximately 5.97 billion.

What is Guangxi Liuzhou Pharm Co Ltd (603368) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.64, and the forward EPS is CN¥1.78.

What is Guangxi Liuzhou Pharm Co Ltd (603368) Price-to-Earnings (P/E) ratio?

Guangxi Liuzhou Pharm Co Ltd current P/E ratio is 9.16, with a forward P/E of 8.44.

Does Guangxi Liuzhou Pharm Co Ltd (603368) pay dividends?

No. Guangxi Liuzhou Pharm Co Ltd does not pay a dividend.

What is Guangxi Liuzhou Pharm Co Ltd (603368) beta (volatility) score?

Guangxi Liuzhou Pharm Co Ltd has a beta of 0.366, indicating lower volatility than the overall market.